Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9243463 | Gastroentérologie Clinique et Biologique | 2005 | 4 Pages |
Abstract
Only seven similar cases have been reported. Toxicity could be associated with the concentration of oxaliplatin in the red blood cells: oxaliplatin binds irreversibly to erythrocytes. This exacerbation could be the consequence of peroperative hemolysis with a redistribution of the pool of intra-erythrocytic oxaliplatin biotransformation products into the plasma. We did not find any relationship with anesthesic or per-operative medications. Studies are necessary to define the precise mechanism and the frequency of this reaction.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Agnès Cournede, Pauline Ries, Karine Richard, Alexandra Guillain, Laëtitia Dahan, Philippe Grandval, Bertrand Pourroy, Vincent Moutardier, Jean Hardwigsen, Diane Braguer, Jean-François Seitz,